MIRA Pharmaceuticals, Inc. (MIRA) ownership: Top institutional holder: VANGUARD GROUP INC ($997350.00). Insider activity: Net Seller (0 buys, 20 sells). SEC EDGAR first-party data.
| Holder | Shares | Market Value | Reported |
|---|---|---|---|
| VANGUARD GROUP INC | 660497.00 | $997350.00 | 2025-12-31 |
| VANGUARD CAPITAL MANAGEMENT LLC | 693912.00 | $742486.00 | 2026-03-31 |
| MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. | 312777.00 | $472293.00 | 2025-12-31 |
| Cross Staff Investments Inc | 359401.00 | $384559.00 | 2026-03-31 |
| GEODE CAPITAL MANAGEMENT, LLC | 290890.00 | $311251.00 | 2026-03-31 |
| VANGUARD FIDUCIARY TRUST CO | 169483.00 | $181347.00 | 2026-03-31 |
| BlackRock, Inc. | 112346.00 | $120210.00 | 2026-03-31 |
| CITADEL ADVISORS LLC | 97976.00 | $111693.00 | 2024-12-31 |
| Insider | Transaction | Value | Date |
|---|---|---|---|
| Sell | null | 2026-06-12 | |
| Sell | null | 2026-06-12 | |
| Sell | null | 2026-06-12 | |
| Sell | null | 2026-06-12 | |
| Sell | null | 2026-03-30 | |
| Sell | null | 2026-03-30 | |
| Sell | null | 2025-10-01 | |
| Sell | null | 2025-10-01 |
Back to MIRA overview · MIRA earnings · All congressional trades
Institutional data from SEC Form 13F. Insider data from SEC Form 4. Congressional data from STOCK Act disclosures. Not personalized investment advice.